Prospects for the use of fecal microbiota transplantation in obese patients with Type 2 Diabetes Mellitus for weight loss and improvement of insulin sensitivity
Open Access
- 12 February 2021
- journal article
- review article
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 23 (6) , 541-547
Abstract
Concerning the uncontrolled growth in the incidence of obesity and Type 2 Diabetes Mellitus (T2DM), numerous research have been carried out to study the pathogenetic mechanisms of progress of these diseases and development of new methods for their prevention and treatment in recent years. T2DM is known to be a multifactorial disease, in the development of which both lifestyle and various environmental factors, and genetic predisposition are involved. At the same time, in recent years, a theory has been discussed that intestinal dysbiosis, which is caused with quantitative and qualitative changes in the gut microbiota (GM) is one of the mechanisms of obesity and T2DM development. At the moment, various methods have been proposed for restoring the normal composition of GM, including the administration of prebiotics and metabiotics that stimulate the growth of gut flora, as well as probiotics, which directly include the necessary beneficial bacteria (mainly Bifidobacterium and Lactobacillus). Fecal microflora transplantation (FMT), which allows transferring an entire microbial community into the recipient's body, rather than individual bacteria is the newest and least studied method of GM normalization. In this connection, this method of GM influencing is of great interest for the prevention and treatment of metabolic diseases.Keywords
This publication has 34 references indexed in Scilit:
- Glucose- and glycaemic factor-lowering effects of probiotics on diabetes: a meta-analysis of randomised placebo-controlled trialsBritish Journal of Nutrition, 2016
- Association of Cardiometabolic Multimorbidity With MortalityJAMA, 2015
- Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and OutlookGastroenterology, 2015
- Manipulating the gut microbiota to maintain health and treat diseaseMicrobial Ecology in Health and Disease, 2015
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and futureThe Lancet, 2014
- Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in MiceScience, 2013
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic SyndromeGastroenterology, 2012
- How Do We Define Cure of Diabetes?Diabetes Care, 2009
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- The gut microbiota as an environmental factor that regulates fat storageProceedings of the National Academy of Sciences, 2004